Haytaian Peter D 4
4 · Elevance Health, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
Transactions
- Tax Payment
Common Stock
2024-03-01$499.11/sh−4,314$2,153,161→ 13,425 total - Award
Common Stock
2024-03-01+2,405→ 15,830 total - Award
Common Stock
2024-03-01+9,152→ 24,982 total - Exercise/Conversion
Common Stock
2024-03-04$166.97/sh+15,000$2,504,550→ 39,982 total - Sale
Common Stock
2024-03-04$500.18/sh−4,206$2,103,757→ 35,776 total - Sale
Common Stock
2024-03-04$500.18/sh−1,889$944,840→ 33,887 total - Sale
Common Stock
2024-03-04$500.18/sh−15,000$7,502,700→ 18,887 total - Award
Employee Stock Option (Right to Buy)
2024-03-01+9,280→ 9,280 totalExercise: $499.11Exp: 2034-03-01→ Common Stock (9,280 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-03-04−15,000→ 4,908 totalExercise: $166.97Exp: 2027-03-01→ Common Stock (15,000 underlying)
Footnotes (7)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
- [F3]Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
- [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023.
- [F5]This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.
- [F6]The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
- [F7]The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted.